QuidelOrtho Adds Fentanyl Test to Its Vitros Systems
QuidelOrtho added the immunoassay for the qualitative detection of fentanyl to its Vitros systems to address the need for opioid testing.
Read MorePosted by Andy Lundin | Apr 11, 2024 | Urinalysis & Toxicology |
QuidelOrtho added the immunoassay for the qualitative detection of fentanyl to its Vitros systems to address the need for opioid testing.
Read MorePosted by Andy Lundin | Apr 5, 2024 | Cardiovascular |
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Read MorePosted by Andy Lundin | Mar 28, 2024 | Molecular Diagnostics |
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children.
Read MorePosted by Andy Lundin | Mar 27, 2024 | Cardiovascular, Molecular Diagnostic Analyzers |
The new high-sensitivity troponin assay is designed for use on the the PATHFAST Biomarker Analyzer from Polymedco.
Read MorePosted by Andy Lundin | Mar 25, 2024 | Unknown Origin & Other Cancer Types |
The tumor cell enumeration assay is a diagnostic test that is promising for establishing the diagnosis of leptomeningeal metastases.
Read More